M&A Transaction Database
Oncology M&A Transactions
Mergers and acquisitions in the Oncology subsector.
Filters
2 shown
DateTransactionAcquirerDeal ValueCountry
Date:Mar 22, 2026
Novartis Acquires Precision Breast Cancer Drug for $2 Billion
Novartis secures a next-generation PI3Kα inhibitor for $2B, enhancing its targeted breast cancer therapy pipeline and precision medicine focus.
Acquirer:Novartis
Deal Value:n/a
Country:🇺🇸
Date:Mar 19, 2026
BriaPro Acquires sCD80 License from BriaCell
BriaPro Therapeutics Corp. secures exclusive rights to Soluble CD80 (sCD80) from BriaCell Therapeutics Corp. in a strategic oncology pipeline consolidation.
Acquirer:BriaPro Therapeutics
Deal Value:n/a
Country:🇨🇦 🇺🇸
Never Miss a Deal
Get weekly investment intelligence. Free forever.
You reached the end (2 deals).